Albuterol sulfate clinical trials
Albuterol sulfate is named as an intervention in 2 current clinical trials in our USA, Germany, Spain, Italy, Denmark, Poland, Czechia, Canada, Mexico, South Korea, Australia and Israel registers. None are recruiting at the moment. The most common phase is Phase 3. The sponsor with the most trials is Teva Branded Pharmaceutical Products R&D LLC (1). The most-studied condition is Asthma.
Where Albuterol sulfate is approved
All regulators →Of the three regulators tracked here, the first to approve Albuterol sulfate was the US, on 1 May 1981.
From the regulators' own registers: FDA Drugs@FDA, the EMA medicines list and Health Canada's Notice of Compliance database. Dates are the first listed approval of a product containing only this substance; combination products and nationally authorised EU medicines are not counted.
What health systems spend on Albuterol sulfate
All medicines →From NHSBSA Prescription Cost Analysis (Open Government Licence v3.0) and CMS State Drug Utilization Data. Both are gross amounts: neither system publishes its discounts or rebates per drug. Products combining several substances are not counted here.
Patient leaflets for Albuterol sulfate
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of Albuterol sulfate
2 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
NCT06052267 · ClinicalTrials.gov ↗ · Asthma
|
Phase 3 | Active, closed | Teva Branded Pharmaceutical Products R&D LLC | USA, Germany, Spain, Italy, Denmark, Poland, Czechia, Canada, Mexico, South Korea, Australia, Israel |
|
Comparison of Bronchodilator Response From Three Different Aerosol Delivery Methods in Patients With COPD Using Hyperpolarized Xe 129 MRI Ventilation Imaging
NCT06271408 · ClinicalTrials.gov ↗ · Chronic Obstructive Pulmonary Disease
|
Phase 1 | Active, closed | Polarean, Inc | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Albuterol sulfate across our data
Ireland · EU · USThe same active substance in our other registers, matched by its exact name. Each entry links to the register record it comes from.
Supply shortages
- Albuterol Sulfate SolutionUS (FDA) · Resolved · updated 27 Aug 2026
Recent approvals
- Albuterol SulfateFDA · 3 May 2024 · Generic (ANDA) · Lexenpharm
Conditions studied with Albuterol sulfate
2 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Teva Branded Pharmaceutical Products R&D LLC | 1 |
| Polarean, Inc | 1 |
By country register
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Albuterol sulfate trials
How many clinical trials are testing Albuterol sulfate?
2 current trials in our USA, Germany, Spain, Italy, Denmark, Poland, Czechia, Canada, Mexico, South Korea, Australia and Israel registers name Albuterol sulfate as a drug or biological intervention, as of the registry sync on 28 October 2026. Completed and withdrawn studies are not counted.
Are Albuterol sulfate trials recruiting patients?
Not at the moment. None of the 2 trials in our registers is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.
Who sponsors Albuterol sulfate clinical trials?
Teva Branded Pharmaceutical Products R&D LLC (1) and Polarean, Inc (1). The number in brackets is how many trials each organisation leads.
Is there a Albuterol sulfate shortage?
The registers we track list 1 entry for Albuterol sulfate: US FDA: resolved. Shortages are product- and country-specific; check with a pharmacist.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Albuterol sulfate works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Albuterol sulfate works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Albuterol sulfate (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 28 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.